161 related articles for article (PubMed ID: 24040098)
41. Mapping the genetic features of T-ALL cases through simplified NGS approach.
García-Aznar JM; Alonso S; Iglesias DU; de Ugarriza PL; López CÁ; Balbín M; Del Castillo TB
Clin Immunol; 2022 Dec; 245():109151. PubMed ID: 36270471
[TBL] [Abstract][Full Text] [Related]
42. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants.
Delabesse E; Bernard M; Landman-Parker J; Davi F; Leboeuf D; Varet B; Valensi F; Macintyre EA
Br J Haematol; 1997 Dec; 99(4):901-7. PubMed ID: 9432040
[TBL] [Abstract][Full Text] [Related]
44. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
45. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
46. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
Cho HS; Kim MK; Bae YK
Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
[TBL] [Abstract][Full Text] [Related]
47. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
Takita J
Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
[TBL] [Abstract][Full Text] [Related]
48. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
49. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract][Full Text] [Related]
50. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
51. [Biological characteristics of T-lineage acute lymphoblastic leukemia in 23 children].
Xiong H; Zhang YD; Hu Q; Sun Y; Liu SY; Zhang LQ; Liu AG; Wang GL
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):605-8. PubMed ID: 20704789
[TBL] [Abstract][Full Text] [Related]
52. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene.
Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A
Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574
[TBL] [Abstract][Full Text] [Related]
53. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
54. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
55. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
[TBL] [Abstract][Full Text] [Related]
56. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
[TBL] [Abstract][Full Text] [Related]
57. Rare and favorable prognosis of pediatric acute lymphoblastic leukemia with TLS-ERG fusion gene: Case report with long-term follow-up and review of literature.
Li S; Huang W; Wu Y; Xu X; Liao C; Tang Y
Cancer Genet; 2021 Aug; 256-257():51-56. PubMed ID: 33894645
[TBL] [Abstract][Full Text] [Related]
58. Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials.
Simon P; Suciu S; Clappier E; Cave H; Sirvent N; Plat G; Thyss A; Mechinaud F; Costa VM; Ferster A; Lutz P; Mazingue F; Plantaz D; Plouvier E; Bertrand Y; Benoit Y; Dastugue N; Rohrlich PS;
Ann Hematol; 2016 Jan; 95(1):93-103. PubMed ID: 26455579
[TBL] [Abstract][Full Text] [Related]
59. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
60. T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia.
Kim H; Kim IS; Chang CL; Kong SY; Lim YT; Kong SG; Cho EH; Lee EY; Shin HJ; Park HJ; Eom HS; Lee H
Ann Lab Med; 2019 Mar; 39(2):125-132. PubMed ID: 30430774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]